CORC

在结果中检索

CORC

浏览/检索结果: 共183条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Cobalt−Iron Oxide Nanosheets for High-Efficiency Solar-Driven CO2−H2O Coupling Electrocatalytic Reactions 会议论文
作者:  Mi, Yuying;  Qiu, Yuan;  Liu, Yifan;  Peng, Xianyin;  Hu, Min
收藏  |  浏览/下载：15/0  |  提交时间：2020/12/18
Real-Time State Recognition of Switches on Electrical Cabinet Panel Using Hybrid Visual Features 会议论文
Virtual, Warwick, United kingdom, July 21-23, 2020
作者:  Zhang YL(张吟龙);  Liang W(梁炜);  Yuan MZ(苑明哲);  Xiao JC(肖金超);  Li, Jun
收藏  |  浏览/下载：3/0  |  提交时间：2021/08/12
Design of Novel Flat Bend Crossed Dipole for Wideband Phased Array Feed Applications 会议论文
Xi'an, China, October 27, 2019 - October 30, 2019
作者:  Fan, Jin;  Zhu, Kai;  Yang, Jian;  Yuan, Hongwei;  Jiang, Peng
收藏  |  浏览/下载：26/0  |  提交时间：2021/04/12
Design of Octave-bandwidth Phased Array Feed for Large Radio Telescope 会议论文
Krakow, Poland, March 31, 2019 - April 5, 2019
作者:  Fan, Jin;  Yang, Jian;  Yan, Yihua;  Zhu, Kai;  Jiang, Peng
收藏  |  浏览/下载：11/0  |  提交时间：2021/04/12
Optimization design of space mirror support based on topology optimization method 会议论文
Shanghai, China, 2019-03-17
作者:  Xu, Wen Jing;  Wang, Wei;  Qu, Yan Jun;  Liu, Bei;  Li, Xu Peng
收藏  |  浏览/下载：35/0  |  提交时间：2019/08/14
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace